BIOMARIN PHARMACEUTICAL INC (BMRN)

Pharmaceutical Preparations

Latest Price

$60.02

TTM P/E

43.18

Normalized P/E

50.37

Div Yield

Book Value

32.27

P/B Ratio

1.86

Valuation metrics

EPS: $1.80

Book value / share: $31.65

Formula: √(22.5 × EPS × BVPS)

Graham Number

$35.80

40% downside

Norm. op. income: $150M (median of 7yr)

Tax rate: 16%

Discount rate: 10%

Growth assumption: zero (EPV is a no-growth value)

Earnings Power Value

$13.34

78% downside

Base FCF: $209M (median of recent 5yr)

Growth: 19%/yr (median YOY, capped at 25%)

Discount rate: 10%

Terminal growth: 3%

Projection horizon: 10 years

DCF Fair Value

$60.81

+1% upside

EPS: $1.80

Target P/E: 50×

Formula: EPS × P/E

P/E Fair Value

$90.00

+50% upside

90.1% held by institutions

Institution	Shares	Value	Ownership %	Change	Filing Date
BlackRock, Inc.	19.82M	$1.12B	10.25%	+683.2K	2026-03-31
Dodge & Cox	14.56M	$822.0M	7.53%	-10.6K	2026-03-31
PRIMECAP MANAGEMENT CO/CA/	14.19M	$801.0M	7.34%	-355.3K	2026-03-31
VANGUARD CAPITAL MANAGEMENT LLC	8.64M	$488.0M	4.47%	--	2026-03-31
VANGUARD PORTFOLIO MANAGEMENT LLC	8.30M	$468.0M	4.29%	--	2026-03-31
AQR CAPITAL MANAGEMENT LLC	7.68M	$429.0M	3.97%	+989.6K	2026-03-31
STATE STREET CORP	7.30M	$412.0M	3.77%	-228.1K	2026-03-31
CITADEL ADVISORS LLC	4.70M	$265.0M	2.43%	+3.02M	2026-03-31
GEODE CAPITAL MANAGEMENT, LLC	3.82M	$215.0M	1.98%	+145.4K	2026-03-31
DIMENSIONAL FUND ADVISORS LP	3.80M	$214.0M	1.97%	+481.2K	2026-03-31